Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to BioSpyder Technologies in July, 2020 for $642,875.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44HG009763-02 | Phase II | 642,875 | July 20, 2020 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in January, 2021 for $252,121.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43ES032514-01 | Phase I | 252,121 | January 1, 2021 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in September, 2018 for $293,532.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HG009763-01A1 | Phase I | 293,532 | September 17, 2018 | |||||||
A STTR Phase I contract was awarded to BioSpyder Technologies in September, 2019 for $349,024.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41HG010638-01 | Phase I | 349,024 | September 6, 2019 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in April, 2021 for $402,266.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM140771-01 | Phase I | 402,266 | April 15, 2021 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in August, 2020 for $224,980.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43ES032368-01 | Phase I | 224,980 | August 11, 2020 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in August, 2019 for $436,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG065039-01 | Phase I | 436,986 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in August, 2020 for $409,096.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL154878-01 | Phase I | 409,096 | August 1, 2020 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in September, 2014 for $700,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG008245-01 | Phase I | 700,000 | September 10, 2014 | |||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies in July, 2017 for $1,485,159.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44ES024107-02 | Phase II | 1,485,159 | July 1, 2017 | |||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies in September, 2016 for $997,861.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HG007815-02 | Phase II | 997,861 | September 22, 2016 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in February, 2016 for $224,517.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG008917-01 | Phase I | 224,517 | February 1, 2016 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in April, 2015 for $213,490.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA187787-01A1 | Phase I | 213,490 | April 1, 2015 | |||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies in May, 2017 for $1,834,744.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HG007339-03 | Phase II | 1,834,744 | May 1, 2017 | |||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies in September, 2017 for $2,317,803.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HG008917-02A1 | Phase II | 2,317,803 | September 15, 2017 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in September, 2013 for $639,477.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG007339-01 | Phase I | 639,477 | September 23, 2013 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies in August, 2017 for $99,992.0 USD from the U.S. Department of Agriculture. | SBIR | 2017-33610-26749 | Phase I | 99,992 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies for $174,496.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG007815-01A1 | Phase I | 174,496 | ||||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies for $149,658.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43DA130011 | Phase I | 149,658 | ||||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies for $634,477.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG007339-01 | Phase I | 634,477 | ||||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies for $149,871.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43ES024107-01 | Phase I | 149,871 | ||||||||
A SBIR Phase I contract was awarded to BioSpyder Technologies for $270,284.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201600059C-0-0-0 | Phase I | 270,284 | ||||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies for $1,248,788.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44DA140052 | Phase II | 1,248,788 | ||||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies for $168,924.0 USD from the U.S. Department of Health & Human Services. | SBIR | 271201400052C-1-0-0 | Phase II | 168,924 | ||||||||
A SBIR Phase II contract was awarded to BioSpyder Technologies in June, 2023 for $1,241,285.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM140771-02 | Phase II | 1,241,285 | June 22, 2023 |